Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group
Clinical trial NCT00313261 · TERMINATED
Trial details
- NCT number
- NCT00313261
- Sponsor
- Bukwang Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.